Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
oxytocin (syntocinon) (1 trial)
allogeneic bone marrow (1 trial)
Fractures, Bone (Phase 2)
Fractures, Ununited (Phase 2)
Hemorrhage (Phase 4)
Postpartum Hemorrhage (Phase 4)
Pseudarthrosis (Phase 2)
Uterine Inertia (Phase 4)
Trials (2 total)
Trial APIs (2 total)